52
Participants
Start Date
April 30, 2013
Primary Completion Date
August 31, 2020
Study Completion Date
August 31, 2020
Milrinone
Milrinone is a potent selective phosphodiesterase (PDE) type III inhibitor which stimulates myocardial function (inotropy), causes peripheral vasodilatation (afterload reduction) and improves myocardial relaxation (lusitropy).
Hospital for Sick Children, Toronto
The Hospital for Sick Children, Toronto
The Hospital for Sick Children
OTHER